RECRUITING

StableEyes With Active Neurofeedback

Talk to us

Conditions

Vestibular DisorderVestibular SchwannomaSpace Motion SicknessMotion Sickness

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Official Title

StableEyes With Active Neurophysiological Feedback

Quick Facts

Study Start:2022-08-08
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05622344

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Provision of signed and dated informed consent form
  2. 2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. 3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
  4. 4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen
  1. 1. Current use of anti-nausea medication
  2. 2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
  3. 3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
  4. 4. Legal blindness (20/200 or worse visual acuity)
  5. 5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Contacts and Locations

Study Contact

Michael Schubert, PhD
CONTACT
4108427403
mschube1@jhmi.edu
Matthew Stewart, MD PhD
CONTACT
4109553492
cstewa16@jhmi.edu

Principal Investigator

Matthew Stewart, MD PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Johns Hopkins University
Baltimore, Maryland, 21287
United States
Naval Medical Research Unit
Dayton, Ohio, 45402
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Matthew Stewart, MD PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-08
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2022-08-08
Study Completion Date2025-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Vestibular Disorder
  • Vestibular Schwannoma
  • Space Motion Sickness
  • Motion Sickness